Experimental discordant hepatic xenotransplantation in the recipient with liver failure: Implications for clinical bridging trials

Journal of the American College of Surgeons

Volumn 191, Issue 1, 2000, Pages 54-64

  Tector, A Joseph ^a,b   Fridell, Jonathan A ^a,b   Ruiz, Phillip ^a,b   Khurana, Reena J ^a,b   Jensen, G ^a,b   Mak, Anton ^a,b   Greinke, Doris ^a,b   Salazar, Julie ^a,b   Stevenson, William ^a,b   Metrakos, Peter ^a,b   Tchervenkov, Jean ^a,b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING DISORDER; DOG; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; LIVER FAILURE; LIVER TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033923675     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(00)00293-3     Document Type: Article

References (33)

1. Byrne G, McCurry K, Martin M, et al. Transgenic pigs expressing human CD59 and decay accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997;63:149-155.
2. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation 1996;62:303-310.
3. Platt J, Fischel R, Matas A, et al. Immunopathology of hyper-acute rejection in a swine-to-primate model. Transplantation 1991;52:214-220.
4. Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyper-acute rejection. Transplantation 1991;52:530-533.
5. Tector AJ, Chen X, Soderland C, Tchervenkov JI. Complement activation in discordant hepatic xenotransplantation. Xenotransplantation 1998;5:257-261.
6. Tector A, Fridell J, Watanabe T, et al. The coagulopathy of discordant hepatic xenotransplantation: studies in the dog-to-pig model. J Hepatol; In Press.
7. Makowka L, Wu GD, Hoffman A, et al. Immunohistopathologic lesions associated with the rejection of a pig-to-human liver xenograft. Transplant Proc 1994;26:1074-1075.
8. Makowka L, Cramer DV, Hoffman A, et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995;59:1654-1659.
9. Calne RY, White HJ, Herbertson BM, et al. Pig-to-baboon liver xenografts. Lancet 1968;1:1176-1178.
10. Valdivia LA, Fung JJ, Demetris AJ, et al. Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation 1994;57:918-922.
11. Valdivia L, Miki T, Rao A, et al. Prolonged survival of guinea pig-to-rat liver xenografts following complement depletion with concomitant use of T/B cell-directed immunosuppression. In: American Society of Transplant Surgeons; Chicago: University of Pennsylvania School of Medicine; 1997:A67.
12. Celli S, Valdivia LA, Fung JJ, Kelly RH. Early recipient-donor switch of the complement type after liver xenotransplantation. Immunol Invest 1997;26:589-600.
13. Bach FH, Fineberg HV. Call for moratorium on xenotransplants [letter and comments]. Nature 1998;391:326.
14. Starzl TE, Rao AS, Murase N, et al. Will xenotransplantation ever be feasible? J Am Coll Surg 1998;180:383-387.
15. Tector AJ, Elias N, Rosenberg L, et al. Mechanisms of resistance to injury in pig livers perfused with blood from patients in liver failure. Transplant Proc 1997;29:966-969.
16. Collins BH, Chari RS, Magee JC, et al. Immunopathology of porcine livers perfused with blood of humans with fulminant hepatic failure. Transplant Proc 1995;27:280-281.
17. Sielaff TD, Hu MY, Rollins MD, et al. An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology 1995;21:796-804.
18. Kalpana K, Ong HS, Soo KC, et al. An improved model of galactosamine-induced fulminant hepatic failure in the pig. J Surg Res 1999;82:121-130.
19. Memsic L, Quinones-Baldrich W, Kaufman R, et al. A comparison of porcine orthotopic liver transplantation using a venous-venous bypass with and without a nonpulsatile perfusion pump. J Surg Res 1986;41:33-40.
20. Todo S, Kam I, Lynch S, Starzl TE. Animal research in liver transplantation with special reference to the dog. Semin Liver Dis 1985;5:309-317.
21. Gibson RL, Soderland C, Henderson WJ Jr, et al. Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect Immun 1995;63:271-279.
22. Valdivia LA, Pan F, Tsugita M, et al. The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. Transplant Proc 1995;27:270.
23. Platt JL, Turman MA, Noreen HJ, et al. An ELISA assay for xenoreactive natural antibodies. Transplantation 1990;49: 1000-1001.
24. Platt JL, Lindman BJ, Chen H, et al. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990;50:817-822.
25. Morgan BP. Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci 1995;32:265-298.
26. Kroshus T, Bolman R, Dalmasso A, et al. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996;61: 1513-1521.
27. Kobayashi T, Taniguchi S, Neethling FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997;64:1255-1261.
28. Platt JL, Lin SS, McGregor CG. Acute vascular rejection. Xenotransplantation 1998;5:169-175.
29. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998;101:1745-1756.
30. Blakely ML, Van der Werf WJ, Berndt MC, et al. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994;58:1059-1066.
31. Knechtle SJ, Kolbeck PC, Tsuchimoto S, et al. Hepatic transplantation into sensitized recipients. Demonstration of hyper-acute rejection. Transplantation 1987;43:8-12.
32. Merion RM, Colletti LM. Hyperacute rejection in porcine liver transplantation. I. Clinical characteristics, histopathology, and disappearance of donor-specific lymphocytotoxic antibody from serum. Transplantation 1990;49:861-868.
33. Colletti LM, Johnson KJ, Kunkel RG, Merion RM. Mechanism of hyperacute rejection in porcine liver transplantation. Antibody-mediated endothelial injury. Transplantation 1994; 57:1357-1363.